2018
DOI: 10.1007/s11864-018-0536-y
|View full text |Cite
|
Sign up to set email alerts
|

Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment

Abstract: Epithelioid hemangioendothelioma (EHE) is an extremely rare sarcoma, as such it can pose a clinical dilemma based solely on its rarity. Also, the spectrum of disease varies greatly between an indolent disease and aggressive disease with widespread metastases. In our clinical practice, the primary focus has been to get a handle on the aggressive nature of the disease, which will then dictate how urgently one needs to treat the patient. Pathological review with immunohistochemistry and molecular characterization… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
139
1
4

Year Published

2018
2018
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 128 publications
(146 citation statements)
references
References 48 publications
2
139
1
4
Order By: Relevance
“…Pseudomyogenic and composite subtypes are rare form of bones and soft tissue hemangioendotheliomas. All of these patterns of growth were not observed in our case [14] , [15] . Hemangiopericytoma characteristically grows in a sheet like, storiform pattern, around an intratumoral staghorn blood vessel.…”
Section: Discussioncontrasting
confidence: 44%
“…Pseudomyogenic and composite subtypes are rare form of bones and soft tissue hemangioendotheliomas. All of these patterns of growth were not observed in our case [14] , [15] . Hemangiopericytoma characteristically grows in a sheet like, storiform pattern, around an intratumoral staghorn blood vessel.…”
Section: Discussioncontrasting
confidence: 44%
“…It originates from endothelial-like cell with a clinical behavior intermediate between hemangioma and angiosarcoma [ 2 ]. Although World Health Organization has recommended that EHE be grouped with angiosarcomas [ 4 ], it has an unpredictable clinical behavior ranging from indolent to aggressively malignant [ 5 ]. Previous studies showed that the 5-year disease-specific survival for EHE was 81% in contrast to approximately 50% mortality rate at 1 year for soft-tissue angiosarcomas [ 6 , 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…The very rare EHE is derived from endothelial origins. These neoplasms are mainly localized to the superficial and deep soft tissues, the bone and the liver . The clinical manifestations and prognosis vary widely, but EHE is classified as an intermediate malignancy—although several experts describe it as a malignant tumour .…”
Section: Discussionmentioning
confidence: 99%
“…Epithelioid hemangioendothelioma (EHE) is a rare tumour of vascular origin with various clinical manifestations. The prognosis ranges from indolent to aggressively progressive disease . Because of its low incidence, only a few case reports describe the clinical manifestations.…”
Section: Introductionmentioning
confidence: 99%